Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Eli Lilly Let a Billion-Dollar Molecule Slip Away, and Make a Fortune for Vertex
Xconomy
Wednesday, August 4, 2010 - 7:52am
tags:
Vertex Pharmaceuticals, Eli Lilly, Telaprevir, hepatitis C
Merck KGaA Said to Seek Buyer for Serono Unit's Fertility-Boosting Drugs
Bloomberg
Wednesday, August 4, 2010 - 7:50am
tags:
Merck KGaA, M&A, fertility drugs, Merck Serono
A Sales Rep Leaves a Promo Leaflet and a Vaccine Lawsuit Is Born
BNET Pharma
Wednesday, August 4, 2010 - 7:48am
tags:
vaccines, drug reps, Pfizer
Teva Pharmaceutical receives European OK for Ratiopharm acquisition, expects to close deal
Yahoo/AP
Wednesday, August 4, 2010 - 7:46am
tags:
Teva Pharmaceuticals, Europe, Ratiopharm
Depomed says Pfizer has not filed lawsuit during 45-day period over version of Neurontin
Yahoo/AP
Wednesday, August 4, 2010 - 7:45am
tags:
Neurontin, Pfizer, Depomed
Merck Plays Down J&J Arbitration but Risk Remains
Seeking Alpha
Wednesday, August 4, 2010 - 7:44am
tags:
Merck, JNJ, Simponi, Remicade
GlaxoSmithKline licenses potential muscle disorder drugs from Five Prime in $139M deal
Yahoo/AP
Wednesday, August 4, 2010 - 7:42am
tags:
GSK, licensing, Five Prime
Enzon Pharma pares 2Q loss after selling assets
Yahoo/AP
Wednesday, August 4, 2010 - 7:40am
tags:
earnings, Enzon
Genzyme and Pfizer, Kissin’ in a Tree? Probably Not.
WSJ Online
Wednesday, August 4, 2010 - 7:39am
tags:
Genzyme, Pfizer, M&A, Sanofi
Vivus slides after analyst downgrades to 'Sell'
Yahoo/AP
Tuesday, August 3, 2010 - 7:01pm
tags:
Vivus, downgrades, obesity, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
What Investors Think About Endo Pharmaceuticals
Motley Fool
Tuesday, August 3, 2010 - 6:59pm
tags:
Endo, investors
Drama Continues: What's Genzyme Worth to Sanofi?
Motley Fool
Tuesday, August 3, 2010 - 6:05pm
tags:
Sanofi, M&A, Genzyme
Cypress Biosciences up 22% in pre-market trading
Marketwatch
Tuesday, August 3, 2010 - 11:15am
tags:
Cypress Bioscience, Ramius, M&A
Cornerstone Therapeutics lands licensing deal with Targacept worth potential $75M
Bizjournals.com
Tuesday, August 3, 2010 - 11:10am
tags:
Targacept, licensing, Cornerstone Therapeutics
Pozen shares tumble on 2Q net, outlook
Bizjournals.com
Tuesday, August 3, 2010 - 11:08am
tags:
Pozen, earnings
Sanofi-Aventis Will Need to Raise Bid to Win Genzyme
WSJ Online
Tuesday, August 3, 2010 - 10:15am
tags:
GSK, JNJ, Genzyme, M&A, Sanofi
Pfizer: Will Earnings Beat Get the Shares Moving?
Seeking Alpha
Tuesday, August 3, 2010 - 10:13am
tags:
Pfizer, earnings
Trius Therapeutics prices shares of downsized IPO
CNBC
Tuesday, August 3, 2010 - 9:59am
tags:
IPOs, Trius Therapeutics
Adult stem cell therapies making rapid progress in human studies
Fierce Biotech Research
Tuesday, August 3, 2010 - 9:58am
tags:
stem cells, Geron
Diabetes drugs dispensed by NHS rockets 43% in five years
Pharma Times, UK
Tuesday, August 3, 2010 - 9:56am
tags:
UK, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.